Compare GHRS & EEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHRS | EEX |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | Ireland | United States |
| Employees | N/A | 821 |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 947.2M | 890.6M |
| IPO Year | 2021 | N/A |
| Metric | GHRS | EEX |
|---|---|---|
| Price | $22.47 | $4.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $41.38 | $7.70 |
| AVG Volume (30 Days) | 193.2K | ★ 671.0K |
| Earning Date | 05-01-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 1.27% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.49 |
| Revenue Next Year | N/A | $6.81 |
| P/E Ratio | ★ N/A | $236.96 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.96 | $3.32 |
| 52 Week High | $24.66 | $5.45 |
| Indicator | GHRS | EEX |
|---|---|---|
| Relative Strength Index (RSI) | 61.36 | 57.04 |
| Support Level | $12.65 | $4.81 |
| Resistance Level | $22.88 | $5.05 |
| Average True Range (ATR) | 1.49 | 0.12 |
| MACD | -0.13 | 0.00 |
| Stochastic Oscillator | 58.59 | 83.59 |
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States, with operations in the United Kingdom (U.K.), France, and other markets. The company is engaged in three complementary business lines: Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division provides B2B e-commerce and digital merchandising solutions to manufacturers and retailers. Emerald's key revenue is derived from the Connections business, its only reportable segment.